Genetic Diseases, Inborn  >>  ciprofloxacin (Q3939)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ciprofloxacin (Q3939) / Bayer, Novartis
NCT00645788 / 2008-008314-40: Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis

Completed
2
288
US, Canada, Europe, RoW
Ciprofloxacin (Cipro Inhale, BAYQ3939), Placebo
Bayer, Novartis
Cystic Fibrosis
01/11
01/11

Download Options